胸主动脉腔内修复术治疗伴降主动脉内膜破损的逆行性A型主动脉壁内血肿
本研究评估胸主动脉腔内修复术(TEVAR)治疗伴降主动脉内膜破损的逆行性A型主动脉壁内血肿(IMH)的安全性和有效性。平均随访37.5个月期间,1例(4.2%)发生永久性截瘫,1例(4.2%)因降主动脉远端内膜破口扩大导致支架远端主动脉扩张而再次干预。结论认为对经选择的患者TEVAR可行且有效,但需要密切监测以管理主动脉相关不良事件。
要点
- 平均随访37.5个月,1例(4.2%)发生永久性截瘫,1例(4.2%)因远端内膜破口扩大致支架远端主动脉扩张而再次干预。
- 术后最新CTA显示升主动脉和降主动脉最大直径均较术前显著减小(均p<0.001),升主动脉及胸降主动脉IMH/假腔完全吸收。
核心结论
- 对经选择的伴降主动脉内膜破损的逆行性A型IMH患者,TEVAR可行且有效,但需要密切监测以管理主动脉相关不良事件。
研究设计与样本
- 2014年1月至2020年10月连续纳入24例伴降主动脉内膜破损(内膜撕裂或溃疡样突起)的逆行性A型IMH患者接受TEVAR,回顾性分析其人口学、临床特征、治疗细节、影像信息和随访结果。
主要发现
- 13例(54.2%)患者降主动脉表现为溃疡样突起,11例(45.8%)表现为内膜撕裂(主动脉夹层)。
- 全部患者TEVAR成功,30天死亡率为0。
- 平均随访37.5个月,1例(4.2%)发生永久性截瘫,1例(4.2%)在2个月随访时因降主动脉远端内膜破口扩大导致支架远端主动脉扩张而再次干预,未观察到其他不良事件。
- 最新CTA显示升主动脉和降主动脉最大直径在TEVAR后均显著减小(均p<0.001),升主动脉及胸降主动脉的IMH/假腔完全吸收。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the safety and efficacy of thoracic endovascular aortic repair (TEVAR) for retrograde type A intramural hematoma (IMH) with intimal disruption in the descending aorta and report our endovascular therapeutic experience. MATERIALS AND METHODS: From January 2014 to October 2020, a total of 24 consecutive patients with retrograde type A IMH with intimal disruption (intimal tear or ulcer-like projection) in the descending aorta underwent TEVAR. The demographics, clinical characteristics, treatment details, imaging information, and follow-up results were reviewed. RESULTS: Among all patients with retrograde type A IMH, 13 (54.2%) patients presented with ulcer-like projection and 11 (45.8%) with intimal tear (aortic dissection) in the descending aorta. Successful TEVAR was achieved in all patients. There was no 30-day mortality. During a mean follow-up of 37.5 months, 1 patient (4.2%) developed permanent paralysis, 1 patient (4.2%) underwent reintervention due to the expansion of the aorta distal to the stent resulting from the enlargement of distal intimal tear at the 2 month follow up, and no other adverse events were observed. The latest computed tomographic angiography images showed that the maximum diameter of the ascending aorta and descending aorta significantly decreased after TEVAR (both p<0.001), and the IMH/false lumen in the ascending aorta and the descending thoracic aorta were completely absorbed. CONCLUSION: Thoracic endovascular aortic repair for selected patients with retrograde type A intramural hematoma that presented with intimal disruption in the descending aorta is feasible and efficient, but close surveillance is needed to manage aortic-related adverse events.
引用
- Wang Y, Song S, Zhou C, et al. Thoracic Endovascular Aortic Repair for Retrograde Type A Intramural Hematoma With Intimal Disruption in the Descending Aorta. J Endovasc Ther. 2021. PMID: 34852656. doi:10.1177/15266028211061268
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。